Literature DB >> 17211638

Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

William Abbott1, Edward Gane, Ingrid Winship, Stephen Munn, Colin Tukuitonga.   

Abstract

Intron 1 of the interferon-gamma (IFNG) gene contains two polymorphisms. The 12 CA-repeat allele of the +875 IFNGCA microsatellite and the T allele of the +A874T single nucleotide polymorphism (SNP) have been associated with increased in vitro IFNG production and a variety of clinical phenotypes. The purpose of this study was to determine whether these polymorphisms influence total serum IgE levels [tsIgE] and the outcome of a hepatitis B virus (HBV) infection. IFNGCA and +A874T were typed in 186 asthmatics of Niuean ancestry and in Polynesian women with a chronic HBV infection (n = 60) and with natural immunity to the HBV (n = 66). The IFNGCA genotype was associated with [tsIgE] in asthmatic children (n = 51, p = 0.004) but not adults (n = 135, p = 0.87). The data were consistent with a co-dominant influence of the 12 CA-repeat allele on high [tsIgE]. The IFNGCA genotype was also associated with the risk for chronic HBV infection (chi (2) = 11.6, p = 0.003) because of a dominant effect of the 12 CA-repeat allele on developing natural immunity in homozygotes (OR = 5.8, p = 0.003) and heterozygotes (OR = 2.7, p = 0.01). Similar associations were found for the T allele of the +A874T SNP. The possibility that these associations were due to linked alleles in the adjacent 783 bp of the promoter and 3'-untranslated region of the IFNG gene was excluded by direct sequencing. In summary, high-IFNG-producing alleles in intron 1 of the IFNG locus are associated with high [tsIgE] in asthmatic children from Niue and with natural immunity to the HBV in Polynesian women. These findings are consistent with a previous report of an association between +875 IFNGCA and [tsIgE] and provide preliminary evidence of a new association with the outcome of an HBV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211638     DOI: 10.1007/s00251-006-0184-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  56 in total

Review 1.  Reliability of statistical associations between genes and disease.

Authors:  Kenneth F Manly
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

2.  Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese.

Authors:  H W Tso; W K Ip; W P Chong; C M Tam; A K S Chiang; Y L Lau
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

3.  Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

Authors:  M K Maini; C Boni; G S Ogg; A S King; S Reignat; C K Lee; J R Larrubia; G J Webster; A J McMichael; C Ferrari; R Williams; D Vergani; A Bertoletti
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

4.  Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China.

Authors:  Xue-Qin Meng; Hu-Guang Chen; Yi-Lin Ma; Ke-Zhou Liu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-05

5.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

Authors:  F D Martinez; A L Wright; L M Taussig; C J Holberg; M Halonen; W J Morgan
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

6.  Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis.

Authors:  Dolores López-Maderuelo; Francisco Arnalich; Rocio Serantes; Alicia González; Rosa Codoceo; Rosario Madero; Juan J Vázquez; Carmen Montiel
Journal:  Am J Respir Crit Care Med       Date:  2003-01-16       Impact factor: 21.405

7.  Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi.

Authors:  Jodene Fitness; Sian Floyd; David K Warndorff; Lifted Sichali; Simon Malema; Amelia C Crampin; Paul E M Fine; Adrian V S Hill
Journal:  Am J Trop Med Hyg       Date:  2004-09       Impact factor: 2.345

8.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia.

Authors:  M R Thursz; D Kwiatkowski; C E Allsopp; B M Greenwood; H C Thomas; A V Hill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

9.  Prevalence of hepatitis B virus infection in Tonga: identifying high risk groups for immunization with hepatitis B vaccine.

Authors:  R B Wainwright; B J McMahon; T R Bender; W L Heyward; S Nakanishi; K Y Wainwright; S Foliaki; S L Erickson; H A Fields
Journal:  Int J Epidemiol       Date:  1986-12       Impact factor: 7.196

10.  A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community.

Authors:  A Milne; G K Allwood; C D Moyes; N E Pearce; K Newell
Journal:  Int J Epidemiol       Date:  1987-03       Impact factor: 7.196

View more
  10 in total

1.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection.

Authors:  Ebrahim Eskandari; Tayebeh Dahmardeh; Fatemeh Dahmardeh; Elham Pahlevani; Malihe Metanat
Journal:  Virusdisease       Date:  2017-08-22

3.  Polymorphisms of the Interferon gamma gene and coronary artery disease in the Korean population.

Authors:  Hak-Jae Kim; Sung Wook Kang; Joo-Ho Chung; Soo-Joong Kim; Bong-Keun Choe
Journal:  Mol Biol Rep       Date:  2011-12-22       Impact factor: 2.316

4.  JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population.

Authors:  Kangmei Chen; Hanyi Min; Xiaopan Wu; Xilin Zhu; Zhuo Li; Hui Li; Ying Liu
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-17

Review 5.  Clinical implications of interferon-γ genetic and epigenetic variants.

Authors:  Nicola L D Smith; David W Denning
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection.

Authors:  Jie Zhou; Ding-Qiang Chen; Vincent K M Poon; Yong Zeng; Fai Ng; Liwei Lu; Jian-Dong Huang; Kwok-Yung Yuen; Bo-Jian Zheng
Journal:  Immunogenetics       Date:  2009-06-02       Impact factor: 2.846

7.  Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.

Authors:  Yu Liu; Wenhui Wan; Fang Fang; Lei Guo; Yusheng Zhao; Xinghu Zhang; Fang Huang
Journal:  J Clin Lab Anal       Date:  2017-10-21       Impact factor: 2.352

8.  Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis.

Authors:  Ahmed Al-Qahtani; Mashael Al-Anazi; Nisha A Viswan; Nisreen Khalaf; Ayman A Abdo; Faisal M Sanai; Hamad Al-Ashgar; Mohammed Al-Ahdal
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.

Authors:  Rong Zhong; Yao Tian; Li Liu; Qian Qiu; Ying Wang; Rui Rui; Bei-Fang Yang; Sheng-Yu Duan; Jun-Xin Shi; Xiao-Ping Miao; Li Wang; Hui Li
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  The injured liver induces hyperimmunoglobulinemia by failing to dispose of antigens and endotoxins in the portal system.

Authors:  Wen Ting Liu; Ying Ying Jing; Zhi Peng Han; Xiao Ning Li; Yan Liu; Fo Bao Lai; Rong Li; Qiu-Dong Zhao; Meng-Chao Wu; Li-Xin Wei
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.